CD163 and Stroke: When specifically looking at the various types of stroke, receptors such as sCD36, sLRP1, and sCD163 should be evaluated as potential therapeutic targets due to the vast diversity in their ligand associations and reported targets, notably in regard to the intrinsic oxidative stress and proinflammation properties of the RBC, the hemoglobin, and the heme.